Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_assertion description "[The positive clinical experience seen in MDS to date coupled with the persistent challenges faced in the treatment of other hematologic malignancies has served as the impetus for further exploration of the therapeutic value of DNMT inhibitors beyond MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_assertion evidence source_evidence_literature NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_assertion SIO_000772 16341239 NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_assertion wasDerivedFrom befree-20140225 NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_assertion wasGeneratedBy ECO_0000203 NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP197797.RAbLZSblEsxXN9ojo-Oq904dU12jgfx2eQ2nruFQm7gw4130_provenance.